Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction

Clinical trial NCT05262803 · RECRUITING

Trial details

NCT number: NCT05262803
Sponsor: Rikke Sorensen
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Myocardial Infarction

Start date: 2022-06-17
Primary completion: 2028-12-01
Enrollment: 2808

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.